Skip to main content
. 2022 Jul 11;18(7):51. doi: 10.1007/s11306-022-01904-9

Table 2.

Metabolites significantly different (p-value < 0.05) when comparing high vs. low IL-13 patient metabolomics

COVID-19 Status IL-13 Level Enriched Metabolite
Severe High 4-imidazolone-5-propanoate
3-methylglutarylcarnitine
Non-Acute High L-homocysteic acid
Low (24R,24'R)-fucosterol epoxide alanyl-poly(glycerolphosphate)
Erucamide
L-Ascorbate 6-phosphate
N2-acetyl-L-lysine
11-Nitro-1-undecane
β –leucine
n-ribosylhistidine
Trp-Phe
trimethylsilyl N,O-bis(trimethylsilyl)serinate